Search - tctmd.com

Displaying 121 - 137 of 137

Sort: Relevancy | Date

Presentation CCVVC 2015

Top 10 Advances of Interventional Cardiology 2014

Presenter: Samin K Sharma

June 17, 2015

News Industry News

Amgen Completes Enrollment In Large Cardiovascular Outcomes Trial Of Repatha™ (Evolocumab) In Patients With High Cholesterol And Clinically Evident Cardiovascular Disease

June 05, 2015

News Daily News

Dual Antiplatelet Therapy Tied to Better Outcomes in High Risk PAD Patients

Leah Lawrence

April 29, 2015

News Daily News

Year in Review: Physicians Highlight the Most Important Interventional News of 2014

Todd Neale

January 12, 2015

News Daily News

Patient-Level Pooled Analysis Supports Bivalirudin Use in Primary PCI

Yael L. Maxwell

January 12, 2015

News Conference News AHA 2014

Long-Term Better than Short-Term Prasugrel After PES Stenting

November 15, 2014

News Daily News

Meta-analysis: High Platelet Reactivity Linked to Increased Stroke Risk after PCI

L.A. McKeown

March 27, 2014

News Daily News

Updated Guidelines Support New Antithrombotics as Warfarin Alternatives in A-fib

L.A. McKeown

August 09, 2012

News Daily News

JAMA Letters Continue Debate Over Genotype, Clopidogrel Response

Caitlin E. Cox

April 12, 2012

News Daily News

PLATO Analysis: PPIs Problematic with Both Ticagrelor, Clopidogrel

Caitlin E. Cox

March 06, 2012

News Daily News

CLI Patients on Statins Show Improved Outcomes After Endovascular Treatment

Caitlin E. Cox

January 26, 2012

News Conference News

ESC Congress 2011: Drugs, Devices Work Together

Caitlin E. Cox

September 06, 2011

News Daily News

Details on Clopidogrel Discontinuation Remain Elusive, Unclear

L.A. McKeown

August 05, 2011

News Daily News

Excess Dyspnea with Ticagrelor Does Not Compromise Mortality Benefit

August 03, 2011

News Daily News

GPIs in Elective PCI: Older Drugs Still Have a Role

February 27, 2011

News Daily News

Dabigatran Recommended as Alternative to Warfarin in A-fib Patients

Jason Kahn

February 13, 2011

CME

Advertisement

Top 10 Advances of Interventional Cardiology 2014

Amgen Completes Enrollment In Large Cardiovascular Outcomes Trial Of Repatha™ (Evolocumab) In Patients With High Cholesterol And Clinically Evident Cardiovascular Disease

Dual Antiplatelet Therapy Tied to Better Outcomes in High Risk PAD Patients

Year in Review: Physicians Highlight the Most Important Interventional News of 2014

Patient-Level Pooled Analysis Supports Bivalirudin Use in Primary PCI

Long-Term Better than Short-Term Prasugrel After PES Stenting

Meta-analysis: High Platelet Reactivity Linked to Increased Stroke Risk after PCI

Updated Guidelines Support New Antithrombotics as Warfarin Alternatives in A-fib

JAMA Letters Continue Debate Over Genotype, Clopidogrel Response

PLATO Analysis: PPIs Problematic with Both Ticagrelor, Clopidogrel

CLI Patients on Statins Show Improved Outcomes After Endovascular Treatment

ESC Congress 2011: Drugs, Devices Work Together

Details on Clopidogrel Discontinuation Remain Elusive, Unclear

Excess Dyspnea with Ticagrelor Does Not Compromise Mortality Benefit

GPIs in Elective PCI: Older Drugs Still Have a Role

Dabigatran Recommended as Alternative to Warfarin in A-fib Patients

A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content